Chemical identity and release specifications for BOC-DL-phenylalanine are established by orthogonal methods because the racemic mixture and its enantiopure forms share an identical molecular formula, molecular weight (265.31 g/mol), and most infrared absorptions. The product is the N-(tert-butoxycarbonyl) derivative of DL-phenylalanine, formally (RS)-2-[(tert-butoxycarbonyl)amino]-3-phenylpropanoic acid, CAS 35599-24-9. Common product-line descriptors include BOC-DL-Phe-OH and N-Boc-DL-phenylalanine. It is supplied as a white to off-white crystalline powder with an assay specification ≥ 98.0% by HPLC area normalization on a C18 column at 210 nm. The melting range, determined by capillary method in accordance with USP <741>, is commonly reported between 82 °C and 86 °C. Specific rotation at 20 °C (c=1, methanol) is 0° ± 1°, consistent with an equimolar mixture of D- and L-enantiomers. The free carboxylic acid is soluble in DMF, DMSO, methanol, and ethyl acetate, slightly soluble in water, and practically insoluble in hexane. Residual water is controlled by Karl Fischer titration to ≤ 0.50%; residual solvents are limited under USP <467> and ICH Q3C Class 3 criteria.

Spectroscopic release data usually include a ¹H NMR in DMSO-d6 where the tert-butyl singlet at δ 1.28–1.36 integrates to nine protons and the benzylic β-protons appear as multiplets near δ 2.90–3.15. FTIR absorbance shows a broad carboxylic acid O-H stretch from 3300–2500 cm⁻¹ and carbonyl signals between 1715 cm⁻¹ and 1680 cm⁻¹. In positive-ion electrospray LC-MS, the protonated molecular ion is monitored at m/z 266.1. These data distinguish the product from unprotected phenylalanine, which lacks the tert-butyl signal, but they do not distinguish the DL form from the enantiopure forms; chiral chromatographic or polarimetric data are required for that purpose.

What Differentiates the Boc-DL Racemate from Enantiopure Phenylalanine Derivatives?

Because the DL form contains equal amounts of enantiomers, it has no significant optical rotation and is not a direct substitute for Boc-L-phenylalanine or Boc-D-phenylalanine in enantioselective synthesis. The enantiopure forms, Boc-L-phenylalanine (CAS 13734-34-4) and Boc-D-phenylalanine (CAS 18942-49-9), have the same molecular weight and similar solubility but exhibit opposite specific rotations reported near ± 25° (c=1, ethanol) under standard polarimetric conditions. The racemate is therefore used for preparing diastereomeric peptide mixtures, for evaluating stereochemical selectivity of coupling reactions, and for generating racemic reference standards. In chiral HPLC method transfer, the DL form supplies both enantiomers in a single injection, which reduces the number of reference solutions and permits direct measurement of resolution. If an enantiopure peptide or chiral intermediate is required, the DL form should be considered a starting material for resolution rather than a drop-in replacement. Crystal habit may also differ; the racemate may crystallize as a denser solid with slower dissolution in cold DMF than the enantiopure powders. Published data for this specific morphology difference is limited, and solids handling should be validated per batch.

Acid Lability and Orthogonal Deprotection Windows in Solid-Phase Synthesis

The Boc group is removed under acid conditions through a tert-butyl carbocation intermediate. In solid-phase peptide synthesis, deprotection is typically performed with 30–50% v/v trifluoroacetic acid in dichloromethane, with contact times of 5–30 min per cycle depending on reactor type and resin loading. Scavengers are added to trap the tert-butyl cation and prevent benzylation of the phenylalanine aromatic ring; triisopropylsilane at 2–5% v/v and water at 1–5% v/v are common. The resulting trifluoroacetate salt is neutralized with a tertiary amine such as N,N-diisopropylethylamine before coupling. For solution-phase synthesis, the Boc group can be removed with 4 M HCl in dioxane at ambient temperature or with TFA in dichloromethane; the free amino component is then isolated as the hydrochloride or trifluoroacetate salt. The deprotected phenylalanine salt is water-soluble, whereas the intact Boc-protected free acid is not, providing a workup solubility switch.

The Boc group is stable to piperidine and to catalytic hydrogenation conditions, which distinguishes it from Fmoc and Cbz protection. In an orthogonal scheme, BOC-DL-phenylalanine can remain intact while an Fmoc-protected amine on another segment is removed with piperidine; the Boc group can then be removed later with acid. Coupling of the sterically hindered Boc amino acid is usually performed with carbodiimide/HOBt systems rather than acyl chlorides. Activation is carried out at 0–5 °C in anhydrous DMF with 1.0–1.2 equivalents of coupling reagent; residual water in the solvent should be ≤ 0.1% for reliable activated-ester formation. The free acid may be coupled to Wang, Merrifield, or 2-chlorotrityl chloride resins after activation or through in situ pre-activation.

In chiral method development, the racemic sample is used to confirm enantiomer separation before quantifying traces of the undesired isomer in enantiopure Boc-phenylalanine batches. A typical approach injects a 0.1 mg/mL solution of BOC-DL-phenylalanine in methanol or acetonitrile on a chiral stationary phase; resolution factor (Rs) between the two peaks should meet the system suitability criterion of not less than 1.5, following liquid chromatography system suitability principles in Ph. Eur. 2.2.29. Peak areas should be approximately equal when the detector response is linear. If peak area ratios deviate by more than ± 5%, non-linear detection or peak overlap should be investigated before quantitative method validation. The DL form is also used to prepare racemic peptide standards for LC-MS/MS; in this context, molecular ion monitoring at m/z 266.1 [M+H]⁺ and fragment ions from loss of the tert-butyloxycarbonyl group may be used for multiple reaction monitoring.

When Residual Water Exceeds 0.5% in the Feedstock or Solvent

If the powder is exposed to relative humidity above 60%, the material can absorb moisture, leading to agglomeration and difficult charging. For moisture-sensitive couplings, pre-drying in a vacuum oven at 25–30 °C for 4 h is applied before dissolution in anhydrous DMF or dichloromethane. Drying should not exceed 40 °C, because prolonged thermal stress can promote slow release of the Boc group and produce trace 2-methylpropene and carbon dioxide. Storage in tightly sealed amber glass or HDPE containers under nitrogen at 2–8 °C is used to reduce moisture uptake and acid-catalyzed decomposition. The product is incompatible with strong mineral acids unless deliberate deprotection is intended; accidental contact with aqueous HCl or TFA will liberate the corresponding phenylalanine salt. It should not be milled under high-humidity air, because mechanical stress in the presence of moisture can introduce amorphous content that alters dissolution. If caking occurs, dissolution in dry ethyl acetate or DMF with gentle warming to 25–30 °C can redissolve the material, but the solution should be used immediately to limit Boc loss.

Process-scale handling of BOC-DL-phenylalanine in a peptide synthesis suite typically employs a solids transfer system under dry nitrogen and a jacketed reactor equipped with a retreat-curve impeller. The solid is charged through a funnel fitted with a nitrogen sweep to prevent moisture ingress. Dissolution in DMF at 0–5 °C may be slow if the crystalline powder is discharged in large lumps; gradual addition under agitation avoids settling on the vessel bottom. For coupling with amino acid esters, the stoichiometry is adjusted to compensate for residual water in the batch, and the reaction is monitored by HPLC until the acid component is consumed. Because the Boc group is stable under the basic conditions used for Fmoc removal, side reactions with piperidine are not observed. The main process bottleneck at scale is not chemical conversion but solid-liquid mass transfer, especially in high-viscosity DMF at low temperature. Published data for this specific racemic solid is limited; therefore, mixing parameters should be established with a representative crystal size distribution.

Orthogonal protection strategy depends on removal selectivity: the Boc group is acid-labile, the Fmoc group is base-labile, and the Cbz group is removed by hydrogenolysis. Table 2 compares three N-protected racemic phenylalanine derivatives. The Boc analogue is preferred when the synthetic route contains base-sensitive groups or when piperidine would cleave the peptide from the resin. The Fmoc analogue is preferred for base-promoted Fmoc SPPS, while the Cbz analogue is selected when acid and base lability must be avoided and a hydrogen atmosphere can be accommodated. The Fmoc derivative also contains the fluorenylmethoxycarbonyl chromophore, with strong UV absorption near 265–301 nm, whereas BOC-DL-phenylalanine is monitored primarily at 210 nm or 254 nm with lower molar absorptivity. These analytical differences affect detector selection and loading limits, not coupling selectivity.

When Fmoc is used elsewhere in a synthetic route, the Boc-protected racemate remains intact during piperidine exposure; this orthogonality is the main selection driver.